Evolent Health Reports Third-Quarter Revenue of $725.37 Million
Revenue rose 51.3% year over year as the net loss narrowed. Growth reflected Performance Suite contract go-lives and expanded oncology services, partly offset by lower membership at certain health-plan clients and contract rate changes.
Story updates
12:19:15 PM UTC
SquawkNews
Evolent reported third-quarter 2026 revenue of $725.4 million, compared with $479.5 million a year earlier, and a net loss of $23.6 million. Adjusted EBITDA was $34.3 million, with adjusted diluted earnings per share of $0.06. The company reiterated its 2026 revenue outlook and raised its Adjusted…
Evolent Health’s third-quarter revenue rose 51.3% year over year, while its net loss narrowed. Revenue growth reflected new Performance Suite contract go-lives and expanded oncology services for an existing customer, partly offset by lower membership at certain health-plan clients and contract rate…